Lincoln Pharmaceuticals Limited

NSE LINCOLN.NS

Lincoln Pharmaceuticals Limited Gross Profit for the year ending March 31, 2024: USD 35.73 M

Lincoln Pharmaceuticals Limited Gross Profit is USD 35.73 M for the year ending March 31, 2024, a 9.21% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Lincoln Pharmaceuticals Limited Gross Profit for the year ending March 31, 2023 was USD 32.72 M, a 0.01% change year over year.
  • Lincoln Pharmaceuticals Limited Gross Profit for the year ending March 31, 2022 was USD 32.72 M, a 10.97% change year over year.
  • Lincoln Pharmaceuticals Limited Gross Profit for the year ending March 31, 2021 was USD 29.48 M, a 15.05% change year over year.
  • Lincoln Pharmaceuticals Limited Gross Profit for the year ending March 31, 2020 was USD 25.62 M, a -1.32% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
SV Wall Street
NSE: LINCOLN.NS

Lincoln Pharmaceuticals Limited

CEO Mr. Mahendrabhai Gulabdas Patel B.A, LLB
IPO Date Dec. 17, 2015
Location India
Headquarters Lincoln House
Employees 1,687
Sector Healthcare
Industries
Description

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Similar companies

KOPRAN.NS

Kopran Limited

USD 2.15

4.35%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.88

1.88%

ALBERTDAVD.NS

Albert David Limited

USD 13.75

1.04%

SEQUENT.NS

Sequent Scientific Limited

USD 1.86

-1.09%

GUFICBIO.NS

Gufic Biosciences Limited

USD 4.85

-1.12%

StockViz Staff

February 8, 2025

Any question? Send us an email